New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2012
05:14 EDTLGCY, ARNA, CAT, PEP, ZIP, NOK, GRA, FUN, DOW, WPRT, KO, VZ, SWK, FTR, COP, LVS, RDS.A, GTLS, HTZ, T, IGT, SKULJim Cramer's "Mad Money"
The markets finishing near their lows for the day on Monday. Jim Cramer said, that while the markets rallied last week in anticipation of good news from Spain, what actually transpired fell far short of expectations. All meaning that the crisis will lumber on. If the news out of Europe really had fixed the problem, investors would have been reaching for gold, noted Cramer, as any true bailout would be seen as inflationary. He said the CurrencyShares Euro Trust (FXE) would have also risen above $130 and the bond yields for most European countries would have fallen even more. Cramer said what the European countries need most is growth; to date, none of the bail out plans offer growth. That's why he continues to recommend stocks that offer domestic security and dividends and are not overly economically sensitive. AT&T (T) and Verizon (VZ) topped Cramer's list, along with cigarette maker Altria (MO). Then, Cramer pitted the upstart Zipcar (ZIP) against the incumbent Hertz Global (HTZ) to see which company rules the rental car market. Since its IPO shares of Zipcar are down 43% and might not yet be done heading lower. Zipcar trades at 29% earnings and has shaky growth prospects, Cramer said he prefers to invest with Hertz, which trades at only 8x earnings with a 12% long-term growth rate. "It's not even a fair fight," Cramer concluded. In the age-old question of which is better, Coca-Cola (KO) or Pepsico (PEP), Cramer announced a stunning change of opinion: He's eliminated Coke from his charitable trust, Action Alerts PLUS, and is now going for Pepsi. CRamer contends, in today's markets what had once been tailwinds for Coke are now changing into headwinds, making Pepsi the winning bet. Not all stocks go up in a straight line, and that's why Cramer circled back to Chart Industries (GTLS), a stock that's up 44% since his original recommendation in February 2011, but also one that's fallen 13% since Cramer last spoke with the company's CEO on April 13. The biggest driver for Chart Industries were last week's announcements by Westport Innovations (WPRT) that they're partnering with equipment giant Caterpillar (CAT) to make natural gas mining equipment and locomotives and the announcement that Royal Dutch Shell (RDS.A) will be building 200 natural gas fueling stations across the U.S. That's good news for Chart, which makes the technology and the tanks to liquefy natural gas for vehicle use. With so many positives, Cramer said that shares of Chart deserve to be much higher than where they trade today, affording investors a terrific entry point. LIGHTNING ROUND: (Bullish) DOW; ARNA; LVS; FUN. (Bearish) LGCY; COP; GRA; SKUL; FTR; NOK; IGT; SWK. Reference Link
News For A;DOW;ARNA;LVS;FUN;LGCY;COP;GRA;SKUL;FTR;NOK;IGT;SWK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 18, 2015
17:15 EDTAAgilent down almost 5% after Q2 earnings results, guidance
16:10 EDTAAgilent sees FY15 EPS $1.67- $1.73, consensus $1.69
Subscribe for More Information
16:07 EDTAAgilent sees Q3 EPS 38c-42c, consensus 42c
Sees Q3 revenue $995M-$1.015B, consensus $1B.
16:06 EDTAAgilent reports Q2 EPS 38c, consensus 39c
Subscribe for More Information
15:00 EDTANotable companies reporting after market close
Subscribe for More Information
13:37 EDTNOKBaidu, Uber teaming up to pursue Nokia's maps unit, Bloomberg reports
Subscribe for More Information
10:01 EDTLVSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTGRAW.R. Grace, Chevron JV to build catalysts plant in Lake Charles, LA
Subscribe for More Information
07:40 EDTLVSLas Vegas Sands downgraded to Neutral from Buy at Goldman
Subscribe for More Information
07:19 EDTSWKElectric Products Group to hold a conference
EPG 2015 is being held in Longboat Key, Florida on May 18-20 with webcasted company presentations to begin on May 18 at 7:30 am; not all company presentations may be webcasted. Webcast Link
06:06 EDTCOPConocoPhillips sees holding CapEx flat for next three years, Reuters reports
ConocoPhillips CEO Ryan Lance told Reuters in an interview that the energy company is planning to hold its capital expenditure level over the next three years. The company cut its 2015 capital budget to $11.5B in January due to the oil price drop, but now sees maintaining the CapEx view for three years despite a slight recovery in oil prices. Reference Link
May 15, 2015
11:08 EDTDOWOmega Advisors gives quarterly update on stakes
NEW STAKES: Targa Resources (TRGP), Targa Resources Partners (NGLS), Humana (HUM), Dow Chemical (DOW), and Twenty-First Century Fox (FOXA). INCREASED STAKES: Kinder Morgan (KMI), Chimera Investment Corporation (CIM), AerCap Holdings (AER), Shire (SHPG), and KKR & Co. (KKR). DECREASED STAKES: eBay (EBAY), Altisource Portfolio Solutions (ASPS), Caesars Entertainment (CZR), Navient (NAVI), and TerraForm Power (TERP). LIQUIDATED STAKES: HCA Holdings (HCA), Gilead (GILD), Cabot Oil & Gas (COG), and Apple (AAPL).
10:34 EDTFTROptions with increasing implied volatility
Subscribe for More Information
10:01 EDTFUNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:01 EDTCOPErin Energy receives government approval for license extension in The Gambia
Subscribe for More Information
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
06:44 EDTCOPEnvironmentalists file lawsuit over oil train safety rules, NY Times says
Subscribe for More Information
05:43 EDTLVSWynn Resorts downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
May 14, 2015
16:08 EDTFUNCedar Fair initiated with an Outperform at Wedbush
Target $69.
07:51 EDTCOPConocoPhillips management to meet with Deutsche Bank
Meeting to be held in Toronto on May 14 hosted by Deutsche Bank.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use